Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$33.26 - $40.48 $144,082 - $175,359
-4,332 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$24.21 - $31.02 $11,063 - $14,176
457 Added 11.79%
4,332 $134,000
Q1 2020

May 08, 2020

BUY
$20.5 - $34.53 $79,437 - $133,803
3,875 New
3,875 $107,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.69B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Citizens Financial Group Inc Portfolio

Follow Citizens Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Financial Group Inc with notifications on news.